ClinicalMatchMate turns complex trial language into clear next steps, so you and your care team can explore cutting-edge treatments with confidence.
Trial snapshot
Phase II immunotherapy for recurrent disease
In plain language
This study is testing a treatment designed to help your immune system target the cancer cells more precisely. Visits are clustered at the beginning and taper off, which may work with your current schedule.
Why ClinicalMatchMate
Clinical trials can be life-changing, but finding one that fits your life is usually the hard part. We translate eligibility criteria into plain language and match patients and caregivers to recruiting trials — honestly, privately, and without the jargon.
We’re a small team rewriting eligibility criteria and trial summaries in language you can actually read — so deciding whether a trial is worth a conversation with your care team takes minutes, not afternoons.
Plain-language, no dark patterns. What we store, with whom, and how to leave — all on one page.
Tell us about your situation in everyday words. No jargon, no pressure to know your diagnosis by heart — short questions you can finish in a few minutes, on a phone, at a kitchen table.
Our job isn’t to convince you to join a trial. It’s to help you understand your options clearly enough that you can decide for yourself.
A low-likelihood match is never dressed up as a strong one. Every result is labeled with what the engine actually returned.
Built for the person navigating a diagnosis — and the family member helping them. Flows work on a phone at a kitchen table, not just a desktop in a clinic.
Every trial page ends with a short list of questions for your doctor. We don’t replace your care team — we help you walk in prepared.
See an exampleHow it works
Four steps. No waiting rooms, no PDF forms, no phone trees. The whole thing is designed to fit between appointments, not replace them.
Start your intakeA short intake in plain English — your condition, where you live, how far you can travel, and what you'd want a trial to fit around.
Recruiting studies, ranked by how well they actually match. Weak matches are labeled weak. Nothing is dressed up to look better than it is.
Eligibility criteria, visit schedules, and study purpose rewritten so you can understand what you'd actually be signing up for.
Save trials, share them with your clinician, and leave with a short list of questions to bring to the next appointment.
Conditions & tools
Plain-language guides for the conditions we cover, paired with the tools we built to turn that understanding into a real next step — a question for your doctor, a shortlist of trials, or just a clearer picture of where you are.
View all condition guidesA cancer that starts in the cells of the breast. Type, stage, and your overall health shape treatment and next steps.
A cancer that starts in the colon or rectum. Treatment depends on where it starts, how far it has spread, and the specific tumor features.
The most common form of lung cancer. Subtype, stage, and biomarker test results shape which treatments are considered.
MCI is a measurable decline in thinking that may or may not progress. Alzheimer’s is the most common cause of progressive dementia—diagnosis and subtype guide treatment and planning.
Long-term loss of kidney filtering ability, often silent until advanced. Stage, cause, and urine protein guide how often you’re monitored and which drugs are adjusted.
A syndrome where the heart can’t pump or fill well enough for the body’s needs. Type, severity, and symptoms shape medications, devices, and follow-up.
A skin cancer that starts in pigment-making cells. Depth, spread to lymph nodes or elsewhere, and molecular test results guide surgery, immunotherapy, or targeted drugs.
Cancers that start in or on the ovaries or related tissues. Subtype and stage determine whether surgery, chemotherapy, targeted therapy, or a combination is discussed first.
A cancer that starts in the pancreas. Where it sits in the pancreas and whether it can be removed with surgery guide the first conversations about treatment.
A cancer that starts in the prostate gland. Risk group, stage, and your goals for quality of life shape whether active surveillance or treatment is recommended.
A long-term condition where the body resists insulin or doesn’t make enough. A1C, kidney function, and heart risk guide medication and follow-up.
A plain-English intake that turns your situation into a ranked list of trials you could actually fit.
Browse studies by condition, location, and distance — no account needed to look around.
Inclusion and exclusion criteria, rewritten into sentences you can bring to your care team.
Keep a short list to share with your clinician, with questions ready for the next appointment.
Where the trials come from
We don’t run trials or recruit for them. We index what’s already public and translate it into something a patient or caregiver can act on.
Why this matters
Clinical research is where the most promising medicine lives first. Whether you can reach it still depends on where you live, who you know, and how fluently you can read a consent form. We think that’s worth fixing.
Targeted biologics, gene therapies, and new devices are often only available through active research — sometimes a decade before they reach standard care.
Enrollment depends on being near an academic center, knowing a specialist, and navigating a system that was built for researchers, not patients.
Eligibility documents are written for reviewers, not readers. Anyone — in any language, at any literacy level — should be able to understand what they'd be signing up for.
Our job is to make the first hour of looking feel less like homework — and more like a real starting point.
See if a trial fits youDesigned for access
A short list of things we treat as first-class — not edge cases. Each card shows what’s live today and what we’re working on next, so you can see the gap, not just the pitch.
We rewrite eligibility criteria into everyday sentences. Translated summaries and interpreter-ready exports are next on the roadmap, so speaking a second language isn't a disqualifier.
Jargon is hidden by default. What matters — what the trial is actually testing, how it might affect your week — comes first.
Distance, scheduling, and caregiving are intake inputs, not afterthoughts. Matching respects what's actually feasible for your week.
Voices from the community
Composite voices drawn from access and equity research. Illustrative — we'll replace these with signed testimonials as we launch.
Ready when you are
Start a free intake. We'll show you what's recruiting near you in plain language — no sales calls, no pressure.